expected revenue of $1billion NZ and can't get above $1.00 SP. if LBY gets any attraction in terms of 3-5million shares sold this could be a x3-5 SP move quite quickly.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%